Open AccessRisk Factors for Mortality in Patients with Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae and Escherichia coli bacteremia
Author(s) -
Hyeonji Seo,
Seongman Bae,
Min Jae Kim,
Yong Pil Chong,
Sung-Han Kim,
SangOh Lee,
SangHo Choi,
Yang Soo Kim
Publication year - 2021
Publication title -
infection and chemotherapy/gam'yeom gwa hwahag yo'beob/infection and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.724
H-Index - 26
eISSN - 2092-6448
pISSN - 1598-8112
DOI - 10.3947/ic.2021.0083
Subject(s) - medicine , bacteremia , klebsiella pneumoniae , interquartile range , odds ratio , tigecycline , septic shock , retrospective cohort study , colistin , carbapenem , confidence interval , gastroenterology , antibiotics , microbiology and biotechnology , sepsis , escherichia coli , biology , biochemistry , gene
Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacterales bacteremia is associated with significant mortality; however, no optimal antibiotic strategy is available. We aimed to evaluate the clinical outcomes according to the antibiotic regimens and identify risk factors for mortality in patients with KPC-producing K. pneumoniae and Escherichia coli bacteremia.